Aug 2026
Electrochemical profiling of plasma pTau-181 levels associated with mild cognitive impairment and Alzheimer's disease using an MXene-gold nanorod interface.
Clinical plasma analysis demonstrated statistically significant differentiation of AD and MCI groups from healthy controls from healthy controls, supporting the relevance of plasma pTau-181 measurement for assessing disease-associated cognitive impairment.
Elangovan Sarathkumar, R. Sasi, R. Menon et al.
· Journal of materials chemist... · 0 citations